Dr Abraham Zavala, new Scientific Director of Tambre and its Foundation
At Tambre, we conduct science to study each case in greater depth, seek answers when the path has been difficult, and continue moving f...
Tambre wins two Fertility Care Awards at ESHRE 2026: recognition for a way of caring for fertility
London has been the setting this year for a new international recognition for Tambre. As part of ESHRE 2026, one of the most important ...
Tambre presents a study at ESHRE 2026 on the role of the oocyte in cases of sperm DNA fragmentation
Tambre presents a study at ESHRE 2026 analysing how sperm DNA fragmentation may affect treatments using patients’ own oocytes and donor...
ESHRE 2026: investigating what cannot be seen to better understand fertility
What can influence whether an oocyte fertilises or not? Can some of the products we use every day leave a trace in the environment wher...
Does IVF increase the risk of preterm birth? We explain
If you’re considering in vitro fertilisation (IVF) treatment, it’s normal to have questions about its safety. You may have read that so...
ROPA Method: epigenetics and who the baby resembles
The ROPA method, or Reception of Oocytes from Partner, has transformed the way female couples can experience shared motherhood. Ho...
Vegan and Vegetarian Diets in Pregnancy and Assisted Reproduction : What You Need to Know
Is a vegan diet safe during pregnancy? Increasingly, women embarking on motherhood – whether naturally or through assisted reproductive...
Perimenopause and Pregnancy: Is It Possible?
Turning 40 – or even 45 – no longer means giving up the desire to become a mother. Increasingly, women are choosing to delay motherhood...
PGT-A in egg donation: when it can provide useful information before embryo transfer
A common question in egg donation
In egg donation treatment, one question that may arise is whether it makes sense to genetically an...
Polycystic ovary syndrome: symptoms, fertility and its new proposed name as PMOS
Polycystic ovary syndrome, known until now as PCOS, is one of the most common hormonal conditions in women of reproductive age. However...